Key result
C/EBPδ exerts opposing, context-dependent effects on inflammation and cancer pathways, curbing tumorigenesis while promoting metastasis.
Answers are grounded in this paper and cite their sources.
The CCAAT/enhancer binding protein delta (CEBPD, C/EBPδ) is a transcription factor that modulates many biological processes including cell differentiation, motility, growth arrest, proliferation, and cell death. The diversity of C/EBPδ's functions depends in part on the cell type and cellular context and can have opposing outcomes. For example, C/EBPδ promotes inflammatory signaling, but it can also inhibit pro-inflammatory pathways, and in a mouse model of mammary tumorigenesis, C/EBPδ reduces tumor incidence but promotes tumor metastasis. This review highlights the multifaceted nature of C/EBPδ's functions, with an emphasis on pathways that are relevant for cancer and inflammation, and illustrates how C/EBPδ emerged from the shadow of its family members as a fascinating "jack of all trades." Our current knowledge on C/EBPδ indicates that, rather than being essential for a specific cellular process, C/EBPδ helps to interpret a variety of cues in a cell-type and context-dependent manner, to adjust cellular functions to specific situations. Therefore, insights into the roles and mechanisms of C/EBPδ signaling can lead to a better understanding of how the integration of different signaling pathways dictates normal and pathological cell functions and physiology.
No takes yet. Share an insight, caveat, or question.
Balamurugan et al. (2013) conducted a review in Inflammation and cancer. C/EBPδ (CCAAT/enhancer binding protein delta) was evaluated. C/EBPδ modulates inflammation and cancer pathways in a cell-type and context-dependent manner, with opposing roles such as reducing tumor incidence while promoting metastasis.
Synapse has enriched 10 related papers. Consider them for comparative context: